This is where MeAgain's GLP-1 app fits in: it centralizes dose timelines, symptom and hydration logs, and lab entries, enabling clinicians to interpret test changes more quickly and precisely
Where evidence is limited, this article clearly distinguishes between established findings and mechanistic plausibility
The first Ozempic lawsuits were filed in August 2023, and more lawsuits continue to be filed today
Generative AI statement The author(s) declared that generative AI was not used in the creation of this manuscript
But before assuming that a GLP-1 medication has stopped working, clinicians will typically consider how the patient is using the drug, such as whether it's being taken properly, with little to no missed doses, and whether it is being stored properly